Scarica l'app Stockscreener
2.24
1.82%
0.04
Dopo l'orario di chiusura:
2.25
0.010
+0.45%
Precedente Chiudi:
$2.20
Aprire:
$2.2
Volume 24 ore:
98,791
Relative Volume:
0.06
Capitalizzazione di mercato:
$5.31M
Reddito:
-
Utile/perdita netta:
$-11.28M
Rapporto P/E:
-0.7442
EPS:
-3.01
Flusso di cassa netto:
$-9.78M
1 W Prestazione:
+5.16%
1M Prestazione:
+2.75%
6M Prestazione:
-70.45%
1 anno Prestazione:
-63.84%
Intervallo 1D:
$2.1766
$2.36
Intervallo di 1 settimana:
$2.10
$2.36
Portata 52W:
$1.62
$14.67
Ensysce Biosciences Inc Stock (ENSC) Company Profile
Nome
Ensysce Biosciences Inc
Settore
Industria
Telefono
(858) 263-4196
Indirizzo
7946 IVANHOE AVENUE, LA JOLLA
Confronta ENSC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENSC
Ensysce Biosciences Inc
|
2.24 | 5.22M | 0 | -11.28M | -9.78M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Ensysce Biosciences Inc Borsa (ENSC) Ultime notizie
What makes Ensysce Biosciences Inc. stock price move sharplyBuild wealth faster with disciplined trading - jammulinksnews.com
How volatile is Ensysce Biosciences Inc. stock compared to the marketStay ahead with advanced stock screening tools - jammulinksnews.com
Has Ensysce Biosciences Inc. Stock Ever Crashed Historical Volatility ReviewTop Performing Stocks - Newser
Why is Ensysce Biosciences Inc. stock attracting strong analyst attentionAccess exclusive market insights for free - jammulinksnews.com
Why Ensysce Biosciences Inc. stock attracts strong analyst attentionFree Top Growth Stock Recommendations - Newser
Is Ensysce Biosciences Inc. a good long term investmentHigh-yield investments - PrintWeekIndia
What drives Ensysce Biosciences Inc. stock priceExponential wealth increase - Autocar Professional
Published on: 2025-07-25 08:23:29 - PrintWeekIndia
What analysts say about Ensysce Biosciences Inc. stockHigh-performance investment picks - jammulinksnews.com
When (ENSC) Moves Investors should Listen - news.stocktradersdaily.com
Ensysce Biosciences Inc. Stock Analysis and ForecastUnprecedented profits - jammulinksnews.com
Ensysce Biosciences initiates Phase 3 study of PF614 - TipRanks
FDA-Reviewed Phase 3 Trial Begins: Revolutionary Opioid Promises Pain Relief Without Abuse Risk - Stock Titan
Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614A Next-Generation OpioidDesigned to Deliver Powerful Pain Relief and Reduce Abuse - The Globe and Mail
How Ensysce Biosciences Inc. stock performs during market volatilityHigh Yield Stock Selection - Newser
NAVY(boat pilot token) Tokenomics ExplainedHigh Return Potential - Newser
Where are the Opportunities in (ENSC) - news.stocktradersdaily.com
Travere Therapeutics (NASDAQ:TVTX) and Ensysce Biosciences (NASDAQ:ENSC) Head to Head Comparison - Defense World
FDA-Designated Breakthrough Pain Drug Advances: New Solution to Opioid Overdose Crisis Shows Promise - Stock Titan
(ENSC) Investment Analysis - news.stocktradersdaily.com
Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Declines By 71.5% - Defense World
Leading Pain Experts Reveal New Opioid Abuse Prevention Technology at World's Largest Pain Conference - Stock Titan
(ENSC) On The My Stocks Page - news.stocktradersdaily.com
Ensysce Biosciences (NASDAQ:ENSC) Trading 1.7% Higher – Here’s What Happened - Defense World
ensysce biosciences appoints baker tilly as new auditor By Investing.com - Investing.com South Africa
ensysce biosciences appoints baker tilly as new auditor - Investing.com
Ensysce Flat on Receiving Grant - Baystreet.ca
Ensysce Biosciences secures additional $5.3M NIDA grant - Investing.com Australia
Ensysce Biosciences Inc Azioni (ENSC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):